WeVote

Bill

Bill

HRES 93

Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.

119th Congress Introduced by Morgan Griffith

HRES 93 streamlines the debate on H.R. 27, amending the Controlled Substances Act to better regulate fentanyl-related substances and combat the opioid crisis.

Motion to reconsider laid on the table Agreed to without objection.
0
WeVote Research Nonpartisan
Bill Summary · HRES 93

Summary of HRES 93

Bill Number: HRES 93
Title: Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
Status: Motion to reconsider laid on the table Agreed to without objection.
Introduced: February 04, 2025
Classification: Resolution

Purpose and Intent

HRES 93 is a resolution that facilitates the consideration of H.R. 27, known as the HALT Fentanyl Act. The primary intent of this resolution is to amend the Controlled Substances Act to address the scheduling of fentanyl-related substances, which have been a significant factor in the ongoing opioid crisis in the United States. The resolution aims to streamline the legislative process for H.R. 27, ensuring that it can be debated and voted on efficiently.

Key Provisions

  • Structured Rule for Consideration: The resolution provides for a structured debate on H.R. 27, allowing for a specific framework within which the bill will be discussed and amended.

  • Waivers of Points of Order: All points of order against the consideration of H.R. 27 are waived, meaning that procedural objections cannot be raised against the bill during its consideration.

  • Adoption of Amendments: An amendment printed in part A of the report is considered adopted without further debate. This amendment includes technical corrections to update statutory references.

  • General Debate: The resolution allocates one hour of general debate on H.R. 27, equally divided between the chair and the ranking minority member of the Committee on Energy and Commerce.

  • Further Amendments: Only one additional amendment (part B) is permitted, which delays the enactment of the bill until certain certifications are made regarding its impact on overdose deaths.

  • Motion to Recommit: The resolution allows for one motion to recommit, providing an opportunity for further discussion or changes before final passage.

Affected Parties

The resolution and the underlying bill (H.R. 27) primarily affect:
- Law Enforcement Agencies: Changes in scheduling may impact how law enforcement handles fentanyl-related substances.
- Healthcare Providers: The amendments could influence prescribing practices and treatment protocols for substance use disorders.
- Public Health Officials: The bill aims to address the opioid crisis, which has significant implications for public health initiatives and funding.

Procedural Aspects

  • Voting Record: The resolution was agreed to by a recorded vote of 215 to 208 on February 5, 2025.
  • Timeline: The resolution was introduced and placed on the House Calendar on February 4, 2025, and was debated and voted on the following day.

Conclusion

HRES 93 serves as a critical step in the legislative process for addressing the fentanyl crisis in the United States. By facilitating the consideration of H.R. 27, the resolution aims to enhance the government's ability to respond to the challenges posed by fentanyl-related substances, ultimately seeking to improve public health and safety.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.